knowledge -WSS

knowledge

author：focus 2025-10-02 21:06:27 - browse：1

Illustration of doctors and researchers using innovative technologies for medicine and healthcare with artificial intelligence. -- health tech coverage from STAT — Adobe

At first glance, the Coalition for Health AI looks like any technology lobbying group. Its membership — including Microsoft, Google, and many of the nation’s largest academic hospitals — forms a formidable presence in Washington.

But on Monday, the coalition forged a different deal with federal regulators. It will work with them to develop quality and safety standards for artificial intelligence, an experiment that will test whether industry and government can effectively partner in the regulation of a fast-moving technology.

The nonprofit announced that its board of directors will include leaders from the Food and Drug Administration and the Office of the National Coordinator for Health Information Technology — agencies that, until now, have been setting up guardrails for AI in health care on their own. Government staffers will now work alongside industry scientists to develop evaluation methods and address new questions posed by generative AI and its emerging applications.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： PBM executives asked to testify by House panel

focus

WSS

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

Home health providers sue Medicare over payment cuts

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Chemotherapy before breast cancer surgery might fuel metastasis

Chemotherapy before breast cancer surgery might fuel metastasis

hotspot

knowledge

knowledge

State Dept. review finds Biden bears some blame for Afghanistan failures

The aspartame in Diet Coke probably isn’t giving you cancer

Cancer drug shortages should be causing more outrage

Has Bernie Sanders reached the limit of his pharma bullying effort?

Apple is now the first public company to be valued at $3 trillion

Crowdfunding for medical bills sidesteps core problem, author says

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

The high cost of giving birth even with insurance

How a small hospital in rural Puerto Rico survived Hurricane Maria

hotspot

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

Medicare wants to send $9 billion to 340B hospitals

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

The creative science of coining drug names

Welsh Carson private equity firm escapes from FTC antitrust case

Primary care doctor shortage won't be solved by free med school tuition

hotspot

knowledge

focus

hotspot